Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106496146A reveals a sulfonic acid ionic liquid catalyzed method for high-yield quinazolinone synthesis, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN101284862B reveals a novel L-carnosine synthesis route achieving >99.5% purity. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN105683159B reveals safer synthesis for calicheamicin derivatives. Enhances supply chain reliability and reduces hazardous solvent use in ADC production.
Patent CN102050766B details a cost-effective synthesis of Amosulalol Hydrochloride from 4-methylacetophenone, offering significant supply chain advantages.
Advanced preparation method for Iopromide using novel intermediates to eliminate bismer byproducts. Ensures high yield and purity for contrast agent manufacturing.
Patent CN106565600A enables acid-catalyzed deuteration. High yield, simple conditions. Reliable supply chain partner for pharmaceutical intermediates.
Patent CN102911229B reveals a greener synthesis route for Cytidine using polymer-supported catalysts, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Patent CN104926704B reveals a mild light-induced route for aziridine intermediates. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced enzymatic and chemical separation process for high-purity escitalopram intermediates. Reduces manufacturing costs and improves supply chain reliability for global API producers.
Patent CN107573285B enables high-purity quinolinone synthesis via Pd-catalyzed decarboxylative cycloaddition, offering cost reduction and scalable supply chain solutions.
Patent CN113214112A reveals a mild, base-catalyzed route for beta-amino acrylate substituted acetonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel intermediates and methods for CPT-11 and mappicine synthesis offering improved yield and chiral control for pharmaceutical manufacturing supply chains.
Patent CN108587991A reveals novel aminotransferase and isomerase pairs for L-allo-Ile production. Discover green enzymatic methods for high-purity pharmaceutical intermediates and cost reduction.
Patent CN101186944B details enzymatic hydrolysis for chiral amino acids. Offers cleaner production and scalable supply chain solutions for pharmaceutical intermediates.
Novel TEMPO-catalyzed oxidative cyclization for 1,2,3,4-tetrahydrocinnoline scaffolds. Mild conditions, high yields, scalable process for anticancer drug development.
Patent CN115948360A details an imine reductase mutant achieving >99.5% conversion and 99.6% ee for nicotine analog intermediates, offering significant cost and supply chain advantages.
Patent CN104630125B reveals engineered E. coli for high-purity statin intermediate synthesis with mild conditions and reduced processing complexity.
Patent CN109837317B details a novel enzymatic method for synthesizing high-purity chiral alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN115417776B offers high-yield 2-amino-1-propanol synthesis. Reduces waste and cost for pharmaceutical intermediates supply chain reliability.
Patent CN119998301A reveals a cost-effective synthesis route for pharmaceutical intermediates. Enhanced supply chain reliability and high-purity output for global buyers.